中間體
艾法韋侖
Efavirenz;SUSTIVA;(4s)-6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2h-3,1-benzoxazin-2-one;L-743726;MDP-266;Efavirenz&Int.;(4S)-6-Chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-1,4-dihydro-(2H)-3,1-benzoxazin-2-one;(4S)-6-Chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one;(S)-Efavirenz;rac Efavirenz-d5;(S)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one;DMP 266;Efavirenz (200 mg);EFAVIRNEZ;EFV;Stocrin;Aryl halide chemistry informer library compound X17;(4S)-6-Chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one;efavuirenz;Efavirenz-D5;Efavirenz&Int.;(-)-6-CHLORO-4-CYCLOPROPYLETHYNYL-4-TRIFLUOROMETHYL-1,4-DIHYDRO-2H-3,1-BENZOXAZIN-2-ONE;(S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one;(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-1H-3,1-benzoxazin-2-one;(4S)-6-Chloro-4-(2-cyclopropylethynyl)-1,;EFAVIRENZ [MART.];DL-535;NSC-742403;Efavirenz & Interleukin 28B;L 743726;HMS2051J08;1ikw;DMP266;L-741211;(4S)-6-chloranyl-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-1H-3,1-benzoxazin-2-one;154598-52-4;EFAVIRENZ [HSDB];Tox21_111582;NCGC00271713-05;Viraday;SCHEMBL37762;Efavirenz & Interleukin 28A;Efavirenz, (S);(S)-6-chloro-4-(Cyclopropylethynyl)-1,4-dihydro-(S)-6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one;Tox21_111582_1;EFV & Interleukin 28A;AC-25006;DMP-266; Efavirenz;Eravirenz;EFV & IL-28A;HY-10572;CCG-101011;EFAVIRENZUM [WHO-IP LATIN];Met-Stromal Cell-derived Factor-1.beta. (Human) & Efavirenz;NCGC00159337-04;GTPL11287;HMS2090N16;EN300-219935;AB00639956-06;SR-01000759360-4;Efavirenz teva;E0997;BC164402;BCP27719;(S)-6-CHLORO-4-(CYCLOPROPYLETHYNYL)-4-(TRIFLUOROMETHYL)-1H-BENZO[D][1,3]OXAZIN-2(4H)-ONE;MFCD05662344;EFV & Interferon lambda-2;NCGC00159337-02;Efavirenz & Interferon lambda-3;(S)-6-Chloro-4-(cyclopropyl-ethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazine-2-one;EFV & Interleukin 28B;AMY229;EFV & Interferon lambda-3;Efavirenz (JAN/USP/INN);CHEMBL223228;EFAVIRENZ [WHO-IP];TELURA COMPONENT EFAVIRENZ;(S)-6-chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-1,4-dihydro-2H-3,1-ben zoxazin-2-one;J-520431;NSC742403;Strocin (TM);BCP9000636;EFAVIRENZ [ORANGE BOOK];AB21723;Efavirenz, >=98% (HPLC);ATRIPLA COMPONENT EFAVIRENZ;CHEBI:119486;Efavirenz- Bio-X;Efavirenz & IL-28B;Sustiva (TN);EFAVIRENZ COMPONENT OF ATRIPLA;Efavirenz & IFNL2;EFAVIRENZ [USP-RS];NCGC00159337-12;2H-3,1-Benzoxazin-2-one, 6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-, (4S)-;EFV & IFNL2;Efavirenz & IL-29;A809555;(Rac)-DMP 266; (Rac)-EFV; (Rac)-L-743726;Efavirenz & Interferon lambda-1;MLS000759465;2H-3,1-Benzoxazin-2-one, 6-chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trif...
C9840
C14H9CLF3NO2
艾法韋侖;施多寧;依法韋倫;依法維侖;依氟維綸;依法韋侖;依非韋倫;(4S)-6-氯-4-(環(huán)丙乙炔)-4-(三氟甲基)-苯并-1,4-二氫噁唑-2-酮;(S)- (+)- 依法韋侖標準品;（S）-（+）-依法韋倫;5-乙基苯并惡唑酮;外消旋依法韋侖;依發(fā)韋侖;依伐韋侖;依法韋侖 USP標準品;依法韋侖,依氟維綸,依非韋倫;依法韋侖相關雜質標準品;依非巴特;依非韋侖;依非韋倫 標準品;(4S)-6-氯-4-(環(huán)丙乙炔)-4-(三氟甲基)-苯并-1,4-二氫唑-2-酮;依法韋;艾法韋瑞
315.68
Efavirenz
訂購此產(chǎn)品
-
訂購、服務熱線：028-82632533
-
| 中文名稱： | 艾法韋侖 | ||
|---|---|---|---|
| 英文名稱: | Efavirenz;SUSTIVA;(4s)-6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2h-3,1-benzoxazin-2-one;L-743726;MDP-266;Efavirenz&Int.;(4S)-6-Chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-1,4-dihydro-(2H)-3,1-benzoxazin-2-one;(4S)-6-Chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one;(S)-Efavirenz;rac Efavirenz-d5;(S)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one;DMP 266;Efavirenz (200 mg);EFAVIRNEZ;EFV;Stocrin;Aryl halide chemistry informer library compound X17;(4S)-6-Chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one;efavuirenz;Efavirenz-D5;Efavirenz&Int.;(-)-6-CHLORO-4-CYCLOPROPYLETHYNYL-4-TRIFLUOROMETHYL-1,4-DIHYDRO-2H-3,1-BENZOXAZIN-2-ONE;(S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one;(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-1H-3,1-benzoxazin-2-one;(4S)-6-Chloro-4-(2-cyclopropylethynyl)-1,;EFAVIRENZ [MART.];DL-535;NSC-742403;Efavirenz & Interleukin 28B;L 743726;HMS2051J08;1ikw;DMP266;L-741211;(4S)-6-chloranyl-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-1H-3,1-benzoxazin-2-one;154598-52-4;EFAVIRENZ [HSDB];Tox21_111582;NCGC00271713-05;Viraday;SCHEMBL37762;Efavirenz & Interleukin 28A;Efavirenz, (S);(S)-6-chloro-4-(Cyclopropylethynyl)-1,4-dihydro-(S)-6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one;Tox21_111582_1;EFV & Interleukin 28A;AC-25006;DMP-266; Efavirenz;Eravirenz;EFV & IL-28A;HY-10572;CCG-101011;EFAVIRENZUM [WHO-IP LATIN];Met-Stromal Cell-derived Factor-1.beta. (Human) & Efavirenz;NCGC00159337-04;GTPL11287;HMS2090N16;EN300-219935;AB00639956-06;SR-01000759360-4;Efavirenz teva;E0997;BC164402;BCP27719;(S)-6-CHLORO-4-(CYCLOPROPYLETHYNYL)-4-(TRIFLUOROMETHYL)-1H-BENZO[D][1,3]OXAZIN-2(4H)-ONE;MFCD05662344;EFV & Interferon lambda-2;NCGC00159337-02;Efavirenz & Interferon lambda-3;(S)-6-Chloro-4-(cyclopropyl-ethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazine-2-one;EFV & Interleukin 28B;AMY229;EFV & Interferon lambda-3;Efavirenz (JAN/USP/INN);CHEMBL223228;EFAVIRENZ [WHO-IP];TELURA COMPONENT EFAVIRENZ;(S)-6-chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-1,4-dihydro-2H-3,1-ben zoxazin-2-one;J-520431;NSC742403;Strocin (TM);BCP9000636;EFAVIRENZ [ORANGE BOOK];AB21723;Efavirenz, >=98% (HPLC);ATRIPLA COMPONENT EFAVIRENZ;CHEBI:119486;Efavirenz- Bio-X;Efavirenz & IL-28B;Sustiva (TN);EFAVIRENZ COMPONENT OF ATRIPLA;Efavirenz & IFNL2;EFAVIRENZ [USP-RS];NCGC00159337-12;2H-3,1-Benzoxazin-2-one, 6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-, (4S)-;EFV & IFNL2;Efavirenz & IL-29;A809555;(Rac)-DMP 266; (Rac)-EFV; (Rac)-L-743726;Efavirenz & Interferon lambda-1;MLS000759465;2H-3,1-Benzoxazin-2-one, 6-chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trif... | ||
| 中文別名： | 艾法韋侖;施多寧;依法韋倫;依法維侖;依氟維綸;依法韋侖;依非韋倫;(4S)-6-氯-4-(環(huán)丙乙炔)-4-(三氟甲基)-苯并-1,4-二氫噁唑-2-酮;(S)- (+)- 依法韋侖標準品;（S）-（+）-依法韋倫;5-乙基苯并惡唑酮;外消旋依法韋侖;依發(fā)韋侖;依伐韋侖;依法韋侖 USP標準品;依法韋侖,依氟維綸,依非韋倫;依法韋侖相關雜質標準品;依非巴特;依非韋侖;依非韋倫 標準品;(4S)-6-氯-4-(環(huán)丙乙炔)-4-(三氟甲基)-苯并-1,4-二氫唑-2-酮;依法韋;艾法韋瑞 | ||
| 英文別名： | Efavirenz | ||
| 產(chǎn)品編輯： | C9840 | ||
| CAS號： | 154598-52-4 | 長期儲存條件： | |
| 分子式： | C14H9CLF3NO2 | 純度： | |
| 分子量： | 315.68 | 檢測方式： | |
| 結構類型： | 產(chǎn)品運輸貨期： | ||
| 植物來源： | 產(chǎn)品包裝： | ||
搜索質檢報告(COA)
暫無下載信息
*半夏(3157321941)*
